REGENERON PHARMACEUTICALS, INC. — SC 13G/A Filings
108 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by REGENERON PHARMACEUTICALS, INC. (REGN), sorted by most recent first. Each row links to the full filing on EdgarLookup. REGENERON PHARMACEUTICALS, INC. has filed 108 SC 13G/A documents with the SEC since 2017. To view all SEC filings by REGENERON PHARMACEUTICALS, INC., see the full filings list.
All
10-K
10-K/A
10-Q
13F-HR
144
15-12G
3
4
4/A
424B1
424B3
424B4
424B5
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFN14A
DEFS14A
FWP
POS EX
PRE 14A
PRES14A
PX14A6G
REGDEX
S-3
S-3/A
S-3ASR
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021814 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000315066-24-001496 | Feb 9, 2024 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001422848-24-000245 | Feb 9, 2024 | — |
| SC 13G/A | — | 0001086364-24-003704 | Jan 25, 2024 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001422849-23-000075 | Feb 13, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016829 | Feb 9, 2023 | — |
| SC 13G/A | — | 0000315066-23-002022 | Feb 9, 2023 | — |
| SC 13G/A | — | 0001306550-23-007818 | Feb 3, 2023 | — |
| SC 13G/A | — | 0000315066-22-001787 | Oct 11, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-020475 | Feb 11, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-020472 | Feb 11, 2022 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001422849-22-000078 | Feb 11, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-018438 | Feb 10, 2022 | — |
| SC 13G/A | — | 0000315066-22-001353 | Feb 9, 2022 | — |
| SC 13G/A | — | 0000834237-22-004576 | Feb 1, 2022 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001422849-21-000062 | Feb 16, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-018970 | Feb 10, 2021 | — |
| SC 13G/A | — | 0000315066-21-001204 | Feb 8, 2021 | — |
| SC 13G/A | — | 0000834237-21-005506 | Feb 1, 2021 | — |
| SC 13G/A | SC 13G/A | 0001422849-20-000101 | Feb 14, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-018803 | Feb 12, 2020 | — |
| SC 13G/A | — | 0000315066-20-001144 | Feb 7, 2020 | — |
| SC 13G/A | — | 0000834237-20-006686 | Feb 6, 2020 | — |
| SC 13G/A | — | 0000315066-19-001261 | Feb 13, 2019 | — |
| SC 13G/A | — | 0000932471-19-005508 | Feb 11, 2019 | — |
| SC 13G/A | — | 0000215457-19-005675 | Feb 6, 2019 | — |
| SC 13G/A | SC 13G/A | 0001422849-18-000102 | Feb 14, 2018 | — |
| SC 13G/A | — | 0000315066-18-001539 | Feb 13, 2018 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-18-000183 | Feb 8, 2018 | — |
| SC 13G/A | — | 0000215457-18-003599 | Jan 29, 2018 | — |
| SC 13G/A | — | 0000315066-17-002000 | Feb 14, 2017 | — |
| SC 13G/A | SC 13G/A | 0001422849-17-000106 | Feb 13, 2017 | — |
| SC 13G/A | — | 0000353480-17-001631 | Jan 25, 2017 | — |
| SC 13G/A | SANDS CAPITAL MANAGEMENT SC 13GA NO1 12-31-2015 (REGENERON PHARMACEUTICALS) | 0001140361-16-052449 | Feb 16, 2016 | — |
| SC 13G/A | SC 13G/A | 0001422849-16-000665 | Feb 16, 2016 | — |
| SC 13G/A | — | 0000315066-16-005398 | Feb 12, 2016 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-16-000995 | Feb 11, 2016 | — |
| SC 13G/A | — | 0000215457-16-005736 | Feb 10, 2016 | — |
| SC 13G/A | — | 0000315066-15-002296 | Feb 13, 2015 | — |
| SC 13G/A | SC 13G/A | 0001422849-15-000286 | Feb 13, 2015 | — |
| SC 13G/A | REGN AS OF 12/31/2014 | 0000080255-15-000318 | Feb 12, 2015 | — |
| SC 13G/A | — | 0000215457-15-000278 | Feb 9, 2015 | — |
| SC 13G/A | — | 0000315066-14-002465 | Feb 14, 2014 | — |
| SC 13G/A | REGN AS OF 12/31/2013 | 0000080255-14-000490 | Feb 13, 2014 | — |
| SC 13G/A | SC 13G/A | 0001422849-14-000247 | Feb 13, 2014 | — |
| SC 13G/A | — | 0001086364-14-001449 | Jan 30, 2014 | — |
| SC 13G/A | — | 0000315066-13-003898 | Sep 10, 2013 | — |
| SC 13G/A | DISCLOSURE DOCUMENT | 0000902219-13-000388 | Feb 14, 2013 | — |
| SC 13G/A | — | 0000315066-13-002752 | Feb 14, 2013 | — |
| SC 13G/A | SC 13G/A | 0001422849-13-000277 | Feb 13, 2013 | — |